There have been no open-market insider trades at Singular Genomics Systems, Inc. in the last 12 months.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
There have been no open-market insider trades at Singular Genomics Systems, Inc. in the last 12 months.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Spaventa Andrew | CEO | Sell | 800 | $19.89 | $16K | SEC |
| Dec 17, 2024 | Spaventa Andrew | CEO | Sell | 180 | $20.16 | $4K | SEC |
| Nov 13, 2024 | Spaventa Andrew | CEO | Sell | 695 | $22.55 | $16K | SEC |
| Sep 18, 2024 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 50,416 | $12.74 | $642K | SEC |
| Sep 18, 2024 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 40,000 | $15.33 | $613K | SEC |
| Sep 18, 2024 | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Buy | 32,000 | $17.21 | $551K | SEC |
| Sep 17, 2024 | Spaventa Andrew | CEO | Sell | 175 | $12.38 | $2K | SEC |
| Nov 20, 2023 | Spaventa Andrew | CEO | Buy | 43,468 | $0.41 | $18K | SEC |
| Nov 20, 2023 | Spaventa Andrew | CEO | Buy | 75,000 | $0.42 | $32K | SEC |
| Nov 20, 2023 | Glezer Eli N. | Executive Officer | Buy | 200,000 | $0.43 | $86K | SEC |
| Aug 15, 2023 | Kamdar Kim P. | Director | Sell | 200,000 | $0.53 | $106K | SEC |
| Aug 15, 2023 | Kamdar Kim P. | Director | Sell | 77,991 | $0.57 | $44K | SEC |
| Aug 15, 2023 | Kamdar Kim P. | Director | Sell | 353,657 | $0.60 | $212K | SEC |
| May 18, 2023 | Glezer Eli N. | Executive Officer | Buy | 170,000 | $0.82 | $139K | SEC |
There were no open-market insider trades in OMIC in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in OMIC were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).